Literature DB >> 10828462

Chaperone-like activity of synucleins.

J M Souza1, B I Giasson, V M Lee, H Ischiropoulos.   

Abstract

Synucleins are a family of small proteins that are predominantly expressed in neurons. The functions of the synucleins are not entirely understood, but they have been implicated in the pathogenesis of several neurodegenerative diseases. Our data show that alpha-, beta- or gamma-synuclein suppresses the aggregation of thermally denatured alcohol dehydrogenase and chemically denatured insulin. The A53T but not the A30P mutant alpha-synuclein was able to inhibit the aggregation of insulin and the chaperone-like activity of alpha-synuclein was lost upon removal of its C-terminal residues 98-140. These results demonstrate that synucleins with the exception of the A30P mutant possess chaperone-like activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828462     DOI: 10.1016/s0014-5793(00)01563-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  55 in total

1.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Authors:  S Waelter; A Boeddrich; R Lurz; E Scherzinger; G Lueder; H Lehrach; E E Wanker
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Dynamic structural flexibility of α-synuclein.

Authors:  Danielle E Mor; Scott E Ugras; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Neurobiol Dis       Date:  2015-12-31       Impact factor: 5.996

3.  Interaction of myocilin with gamma-synuclein affects its secretion and aggregation.

Authors:  Irina Surgucheva; Bum-Chan Park; Beatrice Y J T Yue; Stanislav Tomarev; Andrei Surguchov
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

4.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

5.  Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation.

Authors:  Junping Yu; Yuri L Lyubchenko
Journal:  J Neuroimmune Pharmacol       Date:  2008-07-17       Impact factor: 4.147

6.  Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.

Authors:  Hiroshige Fujishiro; Yoshio Tsuboi; Wen-Lang Lin; Hirotake Uchikado; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2008-04-30       Impact factor: 17.088

7.  Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration.

Authors:  Elpida Tsika; Maria Moysidou; Jing Guo; Mimi Cushman; Patrick Gannon; Raphael Sandaltzopoulos; Benoit I Giasson; Dimitri Krainc; Harry Ischiropoulos; Joseph R Mazzulli
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

Review 8.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

Review 9.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

10.  TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.

Authors:  Mickael Decressac; Bengt Mattsson; Pia Weikop; Martin Lundblad; Johan Jakobsson; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.